Cargando…
Duchenne muscular dystrophy cell culture models created by CRISPR/Cas9 gene editing and their application in drug screening
Gene editing methods are an attractive therapeutic option for Duchenne muscular dystrophy, and they have an immediate application in the generation of research models. To generate myoblast cultures that could be useful in in vitro drug screening, we have optimised a CRISPR/Cas9 gene edition protocol...
Autores principales: | Soblechero-Martín, Patricia, Albiasu-Arteta, Edurne, Anton-Martinez, Aina, de la Puente-Ovejero, Laura, Garcia-Jimenez, Iker, González-Iglesias, Gabriela, Larrañaga-Aiestaran, Irene, López-Martínez, Andrea, Poyatos-García, Javier, Ruiz-Del-Yerro, Estíbaliz, Gonzalez, Federico, Arechavala-Gomeza, Virginia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440673/ https://www.ncbi.nlm.nih.gov/pubmed/34521928 http://dx.doi.org/10.1038/s41598-021-97730-5 |
Ejemplares similares
-
Utrophin modulator drugs as potential therapies for Duchenne and Becker muscular dystrophies
por: Soblechero‐Martín, Patricia, et al.
Publicado: (2021) -
An Overview of Alternative Splicing Defects Implicated in Myotonic Dystrophy Type I
por: López-Martínez, Andrea, et al.
Publicado: (2020) -
A multicenter comparison of quantification methods for antisense oligonucleotide-induced DMD exon 51 skipping in Duchenne muscular dystrophy cell cultures
por: Hiller, Monika, et al.
Publicado: (2018) -
Identification of de novo Mutations of Duchénnè/Becker Muscular Dystrophies in Southern Spain
por: Garcia, Susana, et al.
Publicado: (2014) -
Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012)